Turning a Compounding Pharmacy Into a Scalable Telehealth Brand, Without Risking the Pharmacy License
The client already held the hard-to-get assets: a licensed compounding pharmacy, LegitScript, and Surescripts. What was missing was the front end and a structure that keeps the pharmacy safe. We built both.
- Industry
- Direct-to-patient telehealth (hair loss and hormone replacement therapy)
- Stage
- Established independent pharmacy launching a new telehealth brand
- Region
- United States (New York, multi-state ambition)
- Engagement
- Business-structure design, platform build, provider-network integration, ongoing retainer
- Services used
- Telehealth website, MDI provider integration, Stripe healthcare payments, patient portal, HIPAA infrastructure, compliance enablement
- Outcomes
- Separated brand and entity, launch-ready telehealth platform, prescriptions routed to the client's own pharmacy, full data and customer ownership
The Client
The client owns an independent compounding pharmacy and has run it for years, and knows the regulated side cold. The pharmacy already held the assets that are hardest to get: a licensed 503A compounding operation, LegitScript certification, Surescripts on the dispensing side, and online payments. The products are compounded medications for hair loss and hormone replacement therapy.
The client had a clear ambition: build a direct-to-patient telehealth brand on top of the pharmacy and grow it into an eight-figure business. What the client did not have was the front end or the technical and legal structure to get there. As the client put it, they had the ideas and needed the execution.
The Challenge
The client owned the back end but had no front end. To sell direct to patients, the client needed a brand, a website, a way to capture demand, and a licensed provider network to write the prescriptions. The pharmacy could dispense, but a pharmacist cannot write the prescriptions.
Ownership structure
In New York, a non-physician cannot own a medical practice. If the pharmacy owned the prescribing side, the practice would be unlicensed and its prescriptions could be void.
Anti-kickback exposure
Federal anti-kickback and self-referral rules apply: if the same owner runs both the prescriber and the pharmacy, and every prescription flows to that pharmacy, regulators can read it as a disguised kickback.
Risk to the pharmacy license
Compounded hair-loss and HRT products are a live regulatory target. If the telehealth service lived inside the pharmacy, an FDA action could take the pharmacy license with it. The pharmacy's LegitScript covered the pharmacy, not a new brand.
The client wanted infrastructure first, then patient acquisition, and wanted to own the data and the customers, so they are never locked into a single vendor. The client needed a written, step-by-step plan they could act on fast.
The Solution
We designed the business structure first, then the build.
- 1
We separated the telehealth brand from the pharmacy into its own entity, the same structure every major direct-to-patient telehealth company uses. A management company owns the brand, the marketing, and the technology. A separate medical corporation, owned by a licensed physician, employs the prescribers and holds the medical license. The pharmacy dispenses under an arm's-length agreement.
- 2
We split the build into two tracks. Track A is the telehealth website: brand, landing pages, patient intake, Stripe payments turned on with LegitScript certification, and the patient portal. Track B is the provider integration through MDI, connecting intake to a licensed provider network and routing each electronic prescription through Surescripts to the client's own pharmacy.
- 3
We built on top of the client's stack instead of replacing it. The client's compounding software, their Surescripts, and their pharmacy LegitScript all stayed in place. Everything runs on HIPAA-eligible infrastructure, with the data and accounts in the client's name and transferable to the client on 30 days' notice.
- 4
We scoped the launch to stay clear of the sharpest risks. New York requires an in-person visit before prescribing controlled substances, so testosterone waits for a later phase. The FDA has flagged compounded topical finasteride, so launch uses oral hair-loss medication and women's HRT only. Compliance shaped the product plan, not the other way around.
- 5
Then we sequenced it: legal foundation first, then the technical build, then certification and a soft launch to a small invited group, then public launch and optimization, then the scale work of a subscription refill engine, deeper accreditation, and multi-state expansion.
Architecture
The structure has three owners and one clean flow. The management company owns the brand, the website, and the technology. A physician-owned medical corporation holds the medical license and the prescribers. The pharmacy dispenses. A patient lands on the brand site, completes intake, and pays. The request goes to the provider network through MDI. A licensed provider approves it, and the electronic prescription routes through Surescripts to the client's pharmacy. Status flows back to the patient portal.
What We Delivered
Business structure
- A separate brand and legal entity that protects the pharmacy license
- A management-company and medical-corporation model that keeps the practice legal in New York
- Arm's-length agreements drafted with the client's healthcare attorney
Telehealth website and payments
- A LegitScript-ready brand site with hair-loss and HRT product pages
- Conversion landing pages for paid acquisition
- Stripe payments, enabled with LegitScript certification, accepting HSA/FSA cards
Provider and pharmacy integration
- A licensed provider network connected through MDI, with no need to hire physicians directly
- Electronic prescriptions routed through Surescripts to the client's own pharmacy
- Prescription status synced back to the patient portal
Ownership and compliance
- HIPAA-eligible infrastructure with the full BAA chain in place
- All data, customers, and code owned by the client, transferable on 30 days' notice
- A launch scope built around current FDA and New York rules
A launch-ready telehealth brand, legally separated from the pharmacy, with prescriptions flowing to the client's own dispensing operation. Delivered as a phased, sequenced plan.
I own the pharmacy and I have the vision. What I needed was the execution and a structure that does not put my license at risk. They gave me a step-by-step plan, not a pitch, just what to build, what it costs, who owns what. The point is I own the customers and the data, and the pharmacy stays protected. That is what made me move fast.Owner, independent compounding pharmacy
Business Impact
The client turned assets they already owned into a business that can scale on its own. The separate entity protects the pharmacy, so growth on the brand side does not put the license at risk. The client owns the customers, the data, and the code, so they are never locked into one vendor or one provider network.
The build sits on top of the existing stack, so nothing already paid for was thrown away. And because the same team stays on through a retainer, the platform keeps improving after launch: a subscription refill engine, deeper accreditation, and expansion into new states when the client is ready.
Technologies Used
Why Scalater
Healthcare platforms take more than code. This one needed the right legal structure, the right provider connection, and a launch scope that respects current FDA and state rules.
We worked as a strategic partner, not a vendor. We designed the entity structure with the client's attorney, connected a provider network without requiring the client to hire physicians, and built everything on top of the pharmacy the client already ran. The data and the customers stay the client's. The result is a brand built to scale, on a foundation that keeps the pharmacy safe.
Ready to launch your telehealth brand?
Book a 30-minute architecture call and we'll map your entity structure, provider network, and compliance path end to end.